These updated guidelines focus on the national drug policy process, strategies and options which can be used by Member States and organizations active in the pharmaceutical sector. Each policy component is discussed, with a focus on current problems and new challenges. And each chapter presents strategies and practical approaches that can be used to improve the situation. All chapters include references to publications that provide additional technical and practical details
This report provides guidance on policies and legislation with regards to availability, accessibilit...
The National Drugs Strategy 2009-16 is a cross cutting area of public policy and service delivery. I...
In 2011, the World Health Organization (WHO) published a series of 21 guidelines to assist governmen...
A national medicines policy developed in a collaborative fashion identifies strategies and provides ...
This policy paper aims to provide decision makers and policy managers with an overview of the basic ...
6.4.2016 Drugs misuse continues to be one of the most significant challenges facing our country. It ...
The National Drugs Strategy 2009-16 is a cross cutting area of public policy and service delivery. I...
The IDPC Drug Policy Guide brings together global evidence, best practice and experiences to provide...
Unlike many other Latin American countries Mexico has no coherent and explicit national pharmaceutic...
Pharmaceutical policy development is a linear and step-wise process that moves from problem statemen...
This paper gives an overview of some recent developments in the tools most commonly used to manage n...
The National Drugs Strategy 2009-16 is based upon a co-ordinated approach across the full range of G...
Drugs misuse continues to be one of the most significant challenges facing our country. It is high...
14.5.2015 Drugs misuse continues to be one of the most significant challenges facing our country.ÂÂ...
This document provides guidelines for those who wish to develop an alcohol and drug policy for the w...
This report provides guidance on policies and legislation with regards to availability, accessibilit...
The National Drugs Strategy 2009-16 is a cross cutting area of public policy and service delivery. I...
In 2011, the World Health Organization (WHO) published a series of 21 guidelines to assist governmen...
A national medicines policy developed in a collaborative fashion identifies strategies and provides ...
This policy paper aims to provide decision makers and policy managers with an overview of the basic ...
6.4.2016 Drugs misuse continues to be one of the most significant challenges facing our country. It ...
The National Drugs Strategy 2009-16 is a cross cutting area of public policy and service delivery. I...
The IDPC Drug Policy Guide brings together global evidence, best practice and experiences to provide...
Unlike many other Latin American countries Mexico has no coherent and explicit national pharmaceutic...
Pharmaceutical policy development is a linear and step-wise process that moves from problem statemen...
This paper gives an overview of some recent developments in the tools most commonly used to manage n...
The National Drugs Strategy 2009-16 is based upon a co-ordinated approach across the full range of G...
Drugs misuse continues to be one of the most significant challenges facing our country. It is high...
14.5.2015 Drugs misuse continues to be one of the most significant challenges facing our country.ÂÂ...
This document provides guidelines for those who wish to develop an alcohol and drug policy for the w...
This report provides guidance on policies and legislation with regards to availability, accessibilit...
The National Drugs Strategy 2009-16 is a cross cutting area of public policy and service delivery. I...
In 2011, the World Health Organization (WHO) published a series of 21 guidelines to assist governmen...